Clinical Applications of Thrombosis and Hemostasis
June 6, 2021 [EDT: 7:00 AM, CEST: 1:00 PM, Beijing 7:00 PM]
Thrombosis and hemostasis tests are of importance for the diagnosis of hemorrhagic diseases and disseminated intravascular coagulation (DIC). They are laboratory determinants for the mechanism of thrombosis occurrence, the classification and diagnosis of thrombotic diseases and thrombophilia, as well as the indices of the monitoring of anticoagulant therapy. Several studies showed that thromboembolic events were a serious complication of coronavirus disease 2019 (COVID-19). Autopsy revealed that the death was associated with pulmonary thromboembolism and DIC. In this session, we invited 3 experienced Chinese professors to present topics on the clinical application of thrombosis and hemostasis tests in the monitoring of new oral anticoagulants, in the diagnosis of thrombosis and hemostasis, and the performance of thrombosis and hemostasis tests in COVID-19 patients.
This webinar comprises of three following presentations of 20 min each followed by 20 min of panel discussion at the end.
Talk 1: Direct oral anticoagulants: Pharmacodynamic evaluation for ensuring safety and efficacy [Prof. Qian Xiang]
Talk 2: The structure and function studies for clinical diagnosis of thrombotic and hemostatic disorders [Prof. Wenman Wu ]
Talk 3: Clinical manifestation and mechanism of thrombocytopenia in COVID-19 patients [Prof. Jiancheng Xu ]
Simultaneous Chinese translation is available!
Certificate of participation will be provided at the end of this webinar. Please feel free to share this event in your social media with #IFCCwebinarClick here to convert to your timezone.